An innovative organoid model mirrors the pancreas' complexity, generating all three key cell types to explore development and ...

Pancreatic cancer is one of the deadliest of all cancers. Only 12% of men diagnosed with pancreatic cancer are alive five years after diagnosis; for women it is 14%.

Adding pamrevlumab to standard chemotherapy did not improve survival in patients with locally advanced pancreatic cancer ...

(Jan. 13, 2025) — An experimental blood test for pancreatic cancer that was developed by Van Andel Institute and University of Pittsburgh scientists is being evaluated by a commercial laboratory ...

An experimental blood test for pancreatic cancer is being evaluated by a commercial laboratory, an important milestone toward making the test available for patients. An experimental blood test for ...

Pancreatic cancer is one of the deadliest ... and extremely deadly," says Group Leader Engelholm from the Finsen Laboratory at Rigshospitalet and the Biotech Research & Innovation Center at ...